Global low molecular weight (LMW) heparin market is experiencing significant growth, with market size estimated at $2.3 billion in 2024 and projected to reach $3.8 billion by 2032, growing at a CAGR of 6.7% during the forecast period. This growth is driven by increasing prevalence of cardiovascular diseases, rising surgical procedures requiring anticoagulation therapy, and growing geriatric...